Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 8 studies | 29% ± 8% | |
type I pneumocyte | 8 studies | 44% ± 19% | |
microglial cell | 6 studies | 34% ± 10% | |
ciliated cell | 6 studies | 30% ± 12% | |
type II pneumocyte | 6 studies | 36% ± 10% | |
epithelial cell | 5 studies | 42% ± 12% | |
cardiac muscle cell | 5 studies | 41% ± 12% | |
club cell | 5 studies | 33% ± 17% | |
macrophage | 5 studies | 21% ± 6% | |
endothelial cell | 4 studies | 29% ± 11% | |
interneuron | 4 studies | 32% ± 11% | |
hepatocyte | 3 studies | 29% ± 7% | |
alveolar macrophage | 3 studies | 21% ± 5% | |
monocyte | 3 studies | 26% ± 8% | |
respiratory goblet cell | 3 studies | 30% ± 14% | |
basal cell | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3136.23 | 245 / 245 | 99% | 26.59 | 496 / 502 |
kidney | 100% | 1237.06 | 89 / 89 | 96% | 8.84 | 866 / 901 |
lung | 100% | 1168.45 | 576 / 578 | 90% | 10.14 | 1044 / 1155 |
liver | 100% | 882.61 | 226 / 226 | 78% | 4.59 | 318 / 406 |
esophagus | 100% | 798.99 | 1439 / 1445 | 74% | 5.03 | 135 / 183 |
skin | 72% | 364.12 | 1298 / 1809 | 91% | 18.74 | 429 / 472 |
pancreas | 83% | 257.48 | 273 / 328 | 77% | 2.95 | 137 / 178 |
breast | 75% | 565.57 | 344 / 459 | 83% | 9.62 | 923 / 1118 |
brain | 83% | 302.85 | 2180 / 2642 | 69% | 4.08 | 487 / 705 |
uterus | 86% | 237.60 | 146 / 170 | 58% | 5.17 | 266 / 459 |
thymus | 99% | 404.17 | 645 / 653 | 42% | 1.65 | 257 / 605 |
stomach | 100% | 1747.12 | 358 / 359 | 35% | 1.60 | 101 / 286 |
bladder | 86% | 276.43 | 18 / 21 | 36% | 2.69 | 180 / 504 |
intestine | 100% | 1074.13 | 965 / 966 | 20% | 1.01 | 105 / 527 |
spleen | 100% | 552.11 | 241 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 11.45 | 77 / 80 |
heart | 94% | 1051.64 | 806 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 5.82 | 27 / 29 |
ovary | 28% | 53.89 | 51 / 180 | 55% | 2.62 | 235 / 430 |
adipose | 70% | 178.33 | 842 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 60% | 3.28 | 27 / 45 |
peripheral blood | 59% | 337.12 | 544 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 43% | 351.56 | 576 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 17% | 39.37 | 45 / 258 | 9% | 0.28 | 20 / 230 |
muscle | 17% | 49.55 | 140 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0034116 | Biological process | positive regulation of heterotypic cell-cell adhesion |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0007275 | Biological process | multicellular organism development |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0010608 | Biological process | post-transcriptional regulation of gene expression |
GO_0036438 | Biological process | maintenance of lens transparency |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0010812 | Biological process | negative regulation of cell-substrate adhesion |
GO_0006486 | Biological process | protein glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016020 | Cellular component | membrane |
GO_0008375 | Molecular function | acetylglucosaminyltransferase activity |
GO_0008109 | Molecular function | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity |
Gene name | GCNT2 |
Protein name | Glucosaminyl (N-acetyl) transferase 2 (I blood group) N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT) |
Synonyms | GCNT5 II NACGT1 |
Description | FUNCTION: Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. .; FUNCTION: [Isoform C]: Determines the expression of the blood group I antigen in erythrocytes. . |
Accessions | Q8N0V5 B7ZBL3 ENST00000379597.7 [Q8N0V5-1] ENST00000644083.4 [Q8N0V5-1] ENST00000642698.1 [Q8N0V5-1] ENST00000643503.2 [Q8N0V5-2] ENST00000410107.5 ENST00000495262.7 [Q8N0V5-1] ENST00000265012.5 [Q8N0V5-3] ENST00000316170.9 [Q8N0V5-2] |